Farther Finance Advisors »

Gt Biopharma shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4k 3.0k 0.79
2025-03-31 $13 6 2.33
2024-12-31 $18 6 3.00

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Gt Biopharma

DRW Holdings
SeaCrest Wealth Management
Citadel Advisors
Geode Capital Management
Two Sigma Securities
Verdence Capital Advisors
Parsons Capital Management
Wells Fargo & Company
BlackRock
Advisor Group Holdings
Wolff Wiese Magana
Newbridge Financial Services Group
Farther Finance Advisors
Tower Research Capital
Spire Wealth Management

View all funds holding Gt Biopharma